Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06652347 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Aug 2026 → Mar 2027
See other at-risk trials from Fox Chase Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 2026 to Mar 2027 Show 4 more changesShow less
    • Study completion pushed from Nov 2026 to May 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Collaborators: details revised at 1 of 1 entry
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2024 to Feb 21, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This Interventional clinical study aims to explore how receiving information about their health and physical abilities affects the treatment decisions of older adults. The study will look at whether sharing detailed assessments of their health and functional status helps older adults better understand their condition and make informed decisions about their care. The main question it aims to answer is if providing this information changes the treatment priorities of older adults, helping them focus on what matters most to them in their medical care.
Trial Details
NCT Number NCT06652347
Lead Sponsor Fox Chase Cancer Center
Collaborators: Merck Sharp & Dohme LLC
Conditions
(from sponsor)		 Care Delivery, Geriatrics, Geriatric Assessment
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov